Phase II trial of weekly erlotinib dosing to reduce duadenal polyp burden associated with familial adenomatous polyposis
Ended Awarded Last action
- Contract number
- HHSN26100012
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $772,416
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 90% obligated
-
- $772,415.77 Current, with exercised options
- $853,948.77 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$118,223 | |
| Funding Only Action | -$24,430 | |
| Funding Only Action | -$15,681 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $402,110 | |
| Change Order | $55,783 | |
| Other Administrative Action | $15,681 | |
| Original award | $457,175 |
About this award
The National Cancer Institute issued a delivery order to Mayo Clinic on September 12, 2016, with a ceiling value of $853,948.77 for a Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
Place of performance is Rochester, Minnesota. The order is priced on a cost-no-fee basis with an ultimate completion date of September 14, 2018.
Quick answers
Who was awarded contract HHSN26100012?
HHSN26100012 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 12, 2016.
How much is contract HHSN26100012 worth?
The government has obligated $772,416 on HHSN26100012. Its potential value, with all options, is $853,949.
Is contract HHSN26100012 an order under another contract?
Yes. HHSN26100012 is a delivery order under HHSN261201200042I, an indefinite delivery contract.
Was contract HHSN26100012 competed?
The extent of competition for HHSN26100012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award